InvestorsObserver
×
News Home

Do Analysts Agree Friday on Abeona Therapeutics Inc (ABEO) Stock's Target Price?

Friday, October 01, 2021 11:07 AM | InvestorsObserver Analysts

Mentioned in this article

Do Analysts Agree Friday on Abeona Therapeutics Inc (ABEO) Stock's Target Price?

InvestorsObserver is giving Abeona Therapeutics Inc (ABEO) an Analyst Rating Rank of 75, meaning ABEO is ranked higher by analysts than 75% of stocks. The average price target for ABEO is $5 and analyst’s rate the stock as a Strong Buy.

Overall Score - 5
Wall Street analysts are rating ABEO a Strong Buy today. Find out what this means to you and get the rest of the rankings on ABEO!

Why are Analyst Ratings Important?

You can learn a lot about a company from looking at it’s financial statements and comparing them to other companies. Analysts who cover an industry in depth can add even more to your research though. They typically follow a particular sector or industry very closely. They also pay attention to and ask questions on earnings conference calls and other events where they might learn information that does show up in the numbers. InvestorsObserver takes the average rating from these analysts, and then percentile ranks those averages. This lets you compare stocks in a much more granular way than just seeing the typical five-tiered rating system used on most of Wall Street.

What's Happening With Abeona Therapeutics Inc Stock Today?

Abeona Therapeutics Inc (ABEO) stock is trading at $1.10 as of 10:54 AM on Friday, Oct 1, a drop of -$0.02, or -1.79% from the previous closing price of $1.12. The stock has traded between $1.09 and $1.14 so far today. Volume today is less active than usual. So far 50,261 shares have traded compared to average volume of 470,010 shares. Click Here to get the full Stock Report for Abeona Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App